What Is DNA? The Complete Guide To The Molecule That Makes You Who You Are

Right now, inside almost every cell of your body, there is a molecule so long that if you uncoiled it completely, it would stretch almost two metres. Every cell. Two metres. Your body contains roughly 37 trillion cells. If you laid all your DNA end to end, it would stretch from the Earth to the Sun and back — more than 600 times.

And yet the entire molecule fits inside a nucleus that is a few millionths of a metre across, coiled and folded with an origami precision so intricate that scientists are still mapping its full three-dimensional architecture. It is compressed by a factor of roughly 50,000. It is copied with an error rate of approximately one mistake per billion base pairs. It has been doing this — replicating, repairing, expressing, regulating — for the roughly 3.8 billion years since life began on Earth.

This molecule is deoxyribonucleic acid. DNA. It is the instruction manual for building and running a living organism. It is the archive of four billion years of evolutionary history. And it is, arguably, the most consequential molecule ever discovered — not just in biology, but in the entire history of science.

Understanding DNA is not optional knowledge for the curious mind. The twenty-first century is the century of genetics. Every major medical advance of the coming decades — from cancer treatment to ageing research to personalised medicine — will be built on what we know about how DNA works, how it fails, and how it can be repaired or edited. This is where that knowledge starts.

Table of Contents

What DNA Is Made Of: The Four-Letter Alphabet of Life

DNA is a polymer — a long chain molecule built from repeating units called nucleotides. Each nucleotide has three components: a sugar molecule called deoxyribose, a phosphate group, and one of four nitrogen-containing bases. The bases are adenine (A), thymine (T), guanine (G), and cytosine (C). The entire genetic information in your cells — every instruction for building every protein in your body, every regulatory signal that controls when and where those proteins are made — is encoded in the sequence of these four letters, arranged along a DNA strand in a specific order that evolution has refined over billions of years.

The DNA molecule is double-stranded: two chains of nucleotides running antiparallel to each other, held together by hydrogen bonds between the bases. Adenine always pairs with thymine (A-T), and guanine always pairs with cytosine (G-C). These specific pairings — first described by the biochemist Erwin Chargaff at Columbia University in the late 1940s, when he noted that in any DNA sample the amount of A always equals T and the amount of G always equals C — are called complementary base pairs, and they are the key to virtually everything DNA does.

The complementarity of the two strands means that each strand carries the same information as the other, just in mirror form. This is how DNA replicates: when a cell divides, the double helix unzips, and each strand serves as a template for building a new complementary strand. The result is two identical double helices where there was one. The information is preserved.

The human genome contains approximately 3.2 billion base pairs in each set of chromosomes — a text in the four-letter alphabet of A, T, G, and C that, if printed out in standard type, would fill roughly 5,000 books of 1,000 pages each. The entire sequence was first read, base pair by base pair, by the Human Genome Project — a 13-year international scientific effort completed in 2003, involving researchers from the United States, United Kingdom, France, Germany, Japan, and China, at a cost of approximately $3 billion. Today, the same sequencing can be done for under $200, in a day, by a machine the size of a desk.

The Discovery of the Double Helix: Science, Rivalry, and a Stolen Glimpse

DNA was first identified in 1869 by the Swiss chemist Friedrich Miescher, who isolated it from white blood cells in surgical bandages — a material he called “nuclein.” For decades its role in heredity was not suspected. Proteins were considered more likely candidates for the genetic material, being more chemically varied.

The case for DNA shifted in 1944 when the American microbiologist Oswald Avery and his colleagues at Rockefeller University demonstrated that DNA, not protein, was responsible for transforming the characteristics of bacteria — the first direct evidence that DNA carried genetic information. The finding was initially controversial and only gradually accepted.

By the early 1950s, several groups were racing to determine the three-dimensional structure of DNA. At King’s College London, the physicist Maurice Wilkins and the X-ray crystallographer Rosalind Franklin were producing X-ray diffraction images of DNA fibres of extraordinary quality. At Cambridge, James Watson and Francis Crick were building physical models of possible structures, guided by Chargaff’s ratios, by Linus Pauling’s model-building techniques, and — crucially — by Franklin’s X-ray data.

The story of how that data reached Watson and Crick is one of science’s most enduring controversies. Photograph 51 — Franklin’s clearest X-ray image of DNA, showing unmistakably the features of a helix — was shown to Watson without Franklin’s knowledge by Wilkins, her estranged colleague. Watson has acknowledged that seeing it was a turning point. He and Crick published their model of the double helix in Nature on April 25, 1953, in a paper of just 800 words and one figure. Franklin’s contribution received only a brief acknowledgment.

In 1962, Watson, Crick, and Wilkins received the Nobel Prize in Physiology or Medicine. Rosalind Franklin had died of ovarian cancer in 1958, at the age of 37. Nobel Prizes are not awarded posthumously. She did not receive one. Franklin’s work paved the way for Watson and Crick’s breakthrough discovery of the DNA double helix, and the question of whether she was adequately credited has been debated ever since.

The double helix paper was immediately recognised as a landmark. It did not just describe a structure — it explained a mechanism. “It has not escaped our notice,” Watson and Crick wrote in their paper, with characteristic understatement, “that the specific pairing we have postulated immediately suggests a possible copying mechanism for the genetic material.” The complementary base pairing meant that replication was self-evident. The structure explained the function. That single observation launched the entire field of molecular biology.

How DNA Is Organised: From Nucleotides to Chromosomes

A DNA molecule two metres long fitting inside a nucleus a few millionths of a metre across requires extraordinary packaging. The solution evolution found is one of the most elegant structural arrangements in biology.

The first level of packaging involves proteins called histones. DNA wraps around histone protein complexes — groups of eight histone proteins — like thread around a spool, forming structures called nucleosomes. Each nucleosome contains about 147 base pairs of DNA wrapped roughly twice around the histone octamer. The nucleosomes are connected by linker DNA, giving the arrangement the appearance of beads on a string when viewed under an electron microscope.

The nucleosomal beads are then coiled and folded into progressively higher-order structures, building up through 30-nanometre fibres and loop domains to the fully condensed chromosomes visible under a light microscope when cells divide. The degree of compaction is not uniform — some regions of the genome are tightly packed into a form called heterochromatin, where genes are generally silenced, while others are loosely organised as euchromatin, where genes are more accessible and actively expressed.

This packaging is not merely structural. It is regulatory. Which genes are expressed — which instructions in the genome are read — depends significantly on how the DNA is packed. The modification of histone proteins, and the addition of chemical marks to DNA itself, constitute a layer of gene regulation that operates above the DNA sequence: epigenetics. This is the territory where environment and experience leave marks on the genome without changing the sequence itself. For a full exploration of this regulatory layer and how it connects to health, behaviour, and inheritance, see our article on epigenetics: how your environment shapes the way your genes work.

Human DNA is organised into 23 pairs of chromosomes — 46 in total in most cells — held in the cell nucleus. Twenty-two pairs are autosomes, carrying the general instructions for building the human body. The 23rd pair are the sex chromosomes: XX in females, XY in males. Each chromosome is a single continuous DNA molecule, extraordinarily long, accompanied by the proteins needed to package and regulate it.

The Central Dogma: How DNA Becomes Life

The discovery of the double helix explained how genetic information is stored and copied. The next question — how does that information actually do anything? — was answered over the following two decades through a series of discoveries that established what Francis Crick called the central dogma of molecular biology.

The central dogma describes the flow of genetic information in living cells: from DNA to RNA to protein. It is not a philosophical dogma but a description of the fundamental information pathways that govern how genes are expressed.

The first step is transcription. When a gene needs to be expressed, the relevant section of DNA is unwound and an enzyme called RNA polymerase reads the DNA sequence and produces a complementary molecule of messenger RNA (mRNA) — a single-stranded copy of the gene written in the closely related four-letter alphabet of RNA (with uracil replacing thymine). The mRNA carries the genetic message out of the nucleus and into the cytoplasm.

The second step is translation. In the cytoplasm, molecular machines called ribosomes read the mRNA sequence and use it as a template to assemble proteins — chains of amino acids whose specific sequence determines their three-dimensional structure and therefore their function. The correspondence between the three-letter codons of the mRNA and the amino acids they specify is the genetic code, cracked by Marshall Nirenberg, Har Gobind Khorana, and Robert Holley between 1961 and 1966, earning them the Nobel Prize in Physiology or Medicine in 1968.

The central dogma was once understood as a strict one-way flow. Reality has proved more complex. Retroviruses — including HIV — use an enzyme called reverse transcriptase to copy their RNA genome back into DNA, which integrates into the host cell’s chromosomes. Some regulatory RNAs feed back to modify DNA packaging and gene expression. A 2025 special issue of the Journal of Molecular Biology dedicated to “Imaging the Central Dogma” documented the complex quantitative relationships between transcription and translation dynamics at the single-cell level, revealing that the relationship between DNA, RNA, and protein is regulated at multiple steps with precision previously unappreciated.

And the RNA revolution has gone further still. We are now in the RNA revolution, propelled by the realisation that genes determine phenotype beyond the foundational central dogma — over 95% of the genome, initially considered junk DNA between protein-coding genes, encodes essential, functionally diverse non-protein-coding RNAs, raising the gene count by at least one order of magnitude. The central dogma is not wrong — it is a simplified model of a far richer reality. For the full story of RNA’s expanding role, see our upcoming article on RNA: the forgotten molecule that controls everything.

DNA Replication: Copying Three Billion Letters with Extraordinary Fidelity

Every time a cell divides, it must copy its entire genome — all 3.2 billion base pairs — with sufficient accuracy that the daughter cells function correctly. This is DNA replication, and it is one of the most remarkable molecular processes in biology.

Replication begins at specific locations in the genome called origins of replication. In humans, there are tens of thousands of these origins, allowing replication to proceed simultaneously from multiple starting points — essential given that copying the entire genome from a single origin would take far too long. At each origin, the double helix is unwound by enzymes called helicases, creating a replication bubble with two replication forks moving in opposite directions.

DNA polymerase — the enzyme that synthesises new DNA — reads the exposed template strand and adds complementary nucleotides one by one, building the new strand in the 5′ to 3′ direction. Because the two strands of DNA run antiparallel, one new strand (the leading strand) is synthesised continuously, while the other (the lagging strand) must be synthesised in short fragments called Okazaki fragments that are later joined together.

The error rate of DNA polymerase is approximately one mistake per 100,000 nucleotides — already impressively low. But additional proofreading mechanisms, built into the polymerase itself and supplemented by mismatch repair pathways that scan freshly replicated DNA for errors, reduce the final error rate to approximately one mistake per billion base pairs. Over the entire genome, this means roughly three errors per cell division — a level of fidelity that allows accurate transmission of genetic information across billions of cell divisions and thousands of generations of organisms.

When these repair mechanisms fail — as they do in certain cancers and inherited disorders — the mutation rate rises, DNA damage accumulates, and cells begin to malfunction. Understanding replication fidelity is central to understanding cancer at the molecular level. For the connection between DNA repair failures and cancer biology, see our article on the genetics of cancer: how DNA mutations drive the disease.

Telomeres: The End of the Chromosome — and a Clock for Ageing

Every time a linear chromosome is replicated, there is a problem at the very ends. DNA polymerase cannot copy the last few nucleotides of a linear template — a consequence of how it synthesises DNA — which means that chromosomes become slightly shorter with each cell division. Left unchecked, this progressive shortening would eventually erode essential genes and cause cellular dysfunction.

The solution is telomeres: repeated sequences of DNA — TTAGGG in humans, repeated thousands of times — that cap the ends of chromosomes like the plastic tips on shoelaces. Telomeres are not genes. Their loss does not immediately damage functional DNA. Instead, they act as buffers, sacrificing their own length to protect the coding regions of chromosomes. When telomeres become critically short, the cell receives a signal to stop dividing — entering a state called senescence — or to undergo programmed cell death.

This shortening — the Hayflick limit, described by Leonard Hayflick in 1961 — is one of the fundamental molecular mechanisms of ageing. Most somatic cells have a finite replicative lifespan. The enzyme telomerase can extend telomeres, resetting the counter — it is highly active in stem cells and germ cells (egg and sperm), preserving their ability to divide indefinitely, but is largely absent from most adult tissues.

Cancer cells exploit this. Telomerase reactivation is a key step in the immortalisation of cancer cells, allowing them to maintain their telomeres and continue to proliferate indefinitely, as Nobel Laureate Elizabeth Blackburn has noted. Approximately 85 to 90% of human cancers show evidence of telomerase reactivation.

The remaining 10 to 15% use an alternative mechanism called the ALT pathway — Alternative Lengthening of Telomeres — which relies on homologous recombination rather than telomerase. A July 2025 study published in Molecular Cell by researchers at Emory University introduced a new tool called BLOCK-ID that shed new light on the molecular mechanics of ALT, revealing how replication stress at chromosome ends triggers the recombination events that allow cancer cells to bypass the telomere limit.

A September 2025 study published in Nature by collaborative teams at Linköping University and the Institute of Cancer Research in the UK uncovered a novel cellular mechanism involving histone modifications that prevents the erroneous repair of chromosome ends — a safeguard that, when disrupted, leads to chromosome fusions and the kind of genomic instability characteristic of cancer and rare premature ageing disorders.

And a December 2025 study in Nature Communications demonstrated that nuclear filamentous actin plays an important role in recruiting telomerase to chromosome ends under replication stress, regulated by the kinases ATR and mTOR — revealing a new layer of telomere maintenance previously unknown. For the full story of telomeres, ageing, and what science is doing about it, see our article on telomeres and ageing: the genetic clocks inside every cell.

What Only 2% of DNA Does — and What the Other 98% Is For

One of the most important revisions in genomics of the past two decades concerns what most of the genome actually does. When the Human Genome Project was completed in 2003, one of the most startling findings was that only about 2% of the human genome codes for proteins — the sequences that carry instructions for building the molecular machines of life. The rest, initially labelled “junk DNA,” appeared to have no function.

That conclusion was wrong, and the revision of it has been one of the most consequential developments in modern biology. The ENCODE project — the Encyclopedia of DNA Elements, a large-scale international research effort — reported in 2012 that at least 80% of the genome shows some evidence of biochemical activity, including binding by transcription factors and production of RNA transcripts. The interpretation of this finding has been debated, with some researchers arguing that “biochemical activity” does not necessarily mean “functional.” But the broader conclusion — that non-coding DNA is not junk — has become firmly established.

The non-coding genome contains regulatory sequences — enhancers, silencers, insulators, and promoters — that control when and where protein-coding genes are expressed. It contains the instructions for thousands of types of non-coding RNA molecules: microRNAs that silence specific mRNAs after transcription, long non-coding RNAs that scaffold regulatory complexes and modulate chromatin structure, ribosomal RNAs that are the structural and catalytic components of ribosomes, and transfer RNAs that carry amino acids to the ribosome during translation. It contains the origins of replication and the centromeres and telomeres essential for chromosome stability. And it contains evolutionary fossils — remnants of ancient viruses, transposable elements, and sequences from our deep evolutionary past whose precise functions are still being discovered.

DeepMind’s AlphaGenome, released in 2025, represents the most powerful computational attempt yet to decode this regulatory genome — predicting how any DNA sequence influences gene expression across different cell types. For a full account of what AlphaGenome can do and what it is revealing about the non-coding genome, see our article on decoding the dark DNA: how DeepMind’s AlphaGenome is revolutionising genetic research.

DNA Damage and Repair: The Genome’s Defence Systems

DNA is not chemically inert. It is under constant assault from sources both external — ultraviolet radiation, ionising radiation, environmental chemicals — and internal — reactive oxygen species produced by the cell’s own metabolism, errors in replication, and spontaneous chemical reactions that modify bases. Estimates suggest that each cell sustains between 10,000 and 100,000 DNA lesions per day.

The vast majority of these are repaired before they cause harm, by an array of DNA repair pathways of remarkable sophistication:

Base excision repair (BER) corrects small chemical modifications to individual bases — oxidised bases, deaminated cytosines, alkylated bases — by excising the damaged base and resynthesising the correct sequence.
Nucleotide excision repair (NER) removes bulkier distortions in the double helix, including the pyrimidine dimers caused by ultraviolet radiation. Defects in NER cause xeroderma pigmentosum, a condition in which extreme sensitivity to sunlight leads to very high cancer rates.
Mismatch repair (MMR) corrects base pair mismatches and insertion-deletion loops that escape polymerase proofreading during replication. Defects in MMR dramatically increase mutation rates and are associated with Lynch syndrome, which predisposes to colorectal and other cancers.
Double-strand break repair addresses the most dangerous form of DNA damage — breaks in both strands of the helix simultaneously. Two major pathways exist: homologous recombination, which uses the sister chromatid as a template for accurate repair, and non-homologous end joining, which is faster but error-prone. The BRCA1 and BRCA2 proteins, mutations in which dramatically increase breast and ovarian cancer risk, are key components of the homologous recombination pathway.

When DNA damage exceeds the capacity of repair systems, or when repair systems themselves are defective, mutations accumulate. Most are harmless. Some are lethal to the cell. A small number alter the cell’s behaviour in ways that can lead to uncontrolled growth — cancer. The relationship between DNA damage, repair failure, and cancer is one of the central narratives of molecular medicine.

The Human Genome Project and What It Changed

The Human Genome Project, launched in 1990 and completed in 2003, was one of the most ambitious scientific undertakings in history — comparable in scale and ambition to the Apollo programme. It produced the first complete reference sequence of the human genome: a 3.2-billion-letter text that formed the foundation for virtually all subsequent genomics research.

The immediate scientific consequences were enormous. The project identified approximately 20,000 to 25,000 protein-coding genes — far fewer than the 100,000 that many scientists had predicted, a finding that shifted the field’s understanding of genetic complexity. It provided the reference against which individual genomes could be compared, enabling the identification of disease-associated variants. It catalysed the development of sequencing technology that reduced costs by a factor of one million within twenty years.

The societal consequences were equally significant. The ENCODE project, the 1000 Genomes Project, the UK Biobank, the All of Us Research Program, and dozens of national genomics initiatives have all built on the Human Genome Project’s foundation. Genome-wide association studies have linked thousands of genetic variants to hundreds of diseases. Pharmacogenomics — the study of how genetic variation affects drug response — is transforming clinical medicine. Newborn screening programmes now test for dozens of genetic conditions in the first days of life. Prenatal genetic diagnosis has become routine in many healthcare systems.

The vision of personalised medicine — treatments tailored to each patient’s individual genetic profile — is progressively moving from aspiration to clinical reality. And the tools that make gene editing possible — from the CRISPR systems that have already produced the world’s first approved gene therapy, Casgevy, to the base editing and prime editing techniques moving through clinical trials — all depend on the foundational knowledge of DNA structure, function, and repair that the Human Genome Project and the science it enabled have provided. For the full story of how CRISPR is already changing medicine, see our article on what is CRISPR? the gene editing revolution that is rewriting human medicine.

Frequently Asked Questions

What does DNA stand for and what does it do?

DNA stands for deoxyribonucleic acid. It is the molecule that stores the genetic instructions for building and running a living organism. These instructions are encoded in the sequence of four chemical bases — adenine (A), thymine (T), guanine (G), and cytosine (C) — arranged along the DNA strand. DNA also carries the regulatory information that controls when and where genes are expressed, and it is passed from parents to offspring, making it the physical basis of inheritance.

What is the double helix structure of DNA?

The double helix is the three-dimensional structure of the DNA molecule, first described by Watson and Crick in 1953. It consists of two strands of nucleotides wound around each other in a spiral, held together by hydrogen bonds between complementary base pairs — adenine with thymine, and guanine with cytosine. The two strands run antiparallel — in opposite directions. The complementary base pairing means each strand carries the same information as the other, enabling accurate replication.

How many genes does a human have?

The human genome contains approximately 20,000 to 25,000 protein-coding genes — sequences of DNA that carry instructions for making specific proteins. This is far fewer than early estimates of 100,000. Protein-coding genes account for only about 2% of the genome; the remaining 98% includes regulatory sequences, non-coding RNAs, and other elements whose functions are still being characterised.

What is DNA replication and why does it matter?

DNA replication is the process by which a cell copies its entire genome before dividing, so that each daughter cell receives a complete set of genetic instructions. The double helix unzips and each strand serves as a template for building a new complementary strand. The final error rate — after proofreading and repair — is approximately one mistake per billion base pairs. Failures in replication fidelity contribute to mutation accumulation, ageing, and cancer.

What is a mutation?

A mutation is a permanent change in the DNA sequence. Mutations can be as small as a single base pair change (a point mutation) or as large as the deletion, duplication, or rearrangement of entire chromosomes. Most mutations are harmless or neutral. Some reduce fitness and are eliminated by natural selection. A small number are beneficial and contribute to evolutionary adaptation. Mutations in specific genes can cause inherited diseases or contribute to cancer.

How does DNA differ between individuals?

Any two humans share approximately 99.9% of their DNA sequence. The 0.1% that differs — roughly 3 million base pairs — includes millions of single nucleotide polymorphisms (SNPs), insertions and deletions, and structural variants. These differences underlie individual variation in appearance, metabolism, disease susceptibility, and drug response. Forensic DNA analysis, ancestry testing, and personalised medicine all depend on characterising this variation.

Sources

About the Author

Baryon is the founder and editor of Web News For Us. Driven by a deep fascination with the biggest unanswered questions in science — from quantum physics and cosmology to the nature of consciousness and the genetic code written into every living cell — he has spent years studying modern physics, biology, and the history of scientific thought. He covers Science & AI, Space, Genetics & Research, and the timeless wisdom of history’s greatest thinkers and mystics.

If you have ever looked at the night sky and felt that pull to understand what is out there or wondered about an entire universe coiled inside your genes, you are in the right place.

Share on Facebook

Post on X

Save

Discover more from Web News For Us

Subscribe to get the latest posts sent to your email.

What Is DNA? The Complete Guide to the Molecule That Makes You Who You Are